Rapid Micro Biosystems, Inc. (RPID) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 2 Buy, 2 Hold.
The consensus price target is $8.00, representing an upside of 265.3% from the current price $2.19.
Analysts estimate Earnings Per Share (EPS) of $-1.08 and revenue of $0.03B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-1.08 vs est $-1.08 (beat +0.3%). 2025: actual $-1.05 vs est $-1.01 (missed -4.3%). Analyst accuracy: 98%.
RPID Stock — 12-Month Price Forecast
$8.00
▲ +265.30% Upside
Average Price Target
Based on 4 Wall Street analysts offering 12-month price targets for Rapid Micro Biosystems, Inc., the price target is $8.00.
The average price target represents a +265.30% change from the last price of $2.19.
RPID Analyst Ratings
Buy
Based on 4 analysts giving stock ratings to Rapid Micro Biosystems, Inc. in the past 3 months
EPS Estimates — RPID
98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$1.08
vs Est –$1.08
▲ 0.3% off
2025
Actual –$1.05
vs Est –$1.01
▼ 4.1% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — RPID
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.028B
vs Est $0.028B
▲ 1.4% off
2025
Actual $0.034B
vs Est $0.034B
▼ 0.2% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
